Prescription drug · ANDA
Fludrocortisone acetate NDC 51407-705
Fludrocortisone acetate .1 mg/1 · Tablet · Oral · Golden State Medical Supply, Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 51407-705-01 | 51407070501 | 100 TABLET in 1 BOTTLE (51407-705-01)Marketed from Jun 10, 2025 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Fludrocortisone acetate
- Generic name (nonproprietary)
- fludrocortisone acetate
- Active ingredients
- Fludrocortisone acetate — .1 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 219251
- Marketing start
- Listing expires
- Identifiers
- Product ID 51407-705_3d863fa4-bdeb-e0a4-e063-6294a90a7cc4SPL ID 3d863fa4-bdeb-e0a4-e063-6294a90a7cc4SPL set ID 3752ff25-8887-5c88-e063-6294a90a345aRxCUI 313979UNII V47IF0PVH4
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N451407070501followed by a unit qualifier and the quantityPackage 51407-0705-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE Fludrocortisone acetate tablets are indicated as partial replacement therapy for primary and secondary adrenocortical insufficiency in Addison's disease and for the treatment of salt-losing adrenogenital syndrome.
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 219251
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Fludrocortisone acetate | Fludrocortisone acetate .1 mg/1 | TabletOral | Zydus Lifesciences Limited | 70771-1893 |
| Fludrocortisone acetate | Fludrocortisone acetate .1 mg/1 | TabletOral | Viona Pharmaceuticals Inc | 72578-164 |